HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bupropion treatment of attention-deficit hyperactivity disorder in adults.

Abstract
The authors treated 19 adults with attention-deficit hyperactivity disorder with an open trial of bupropion. These patients had received maintenance stimulant medication or monoamine oxidase inhibitors for an average of 3.7 years. Fourteen of the patients experienced moderate to marked benefit from bupropion; ten of these patients chose to continue bupropion rather than their former medication. These results suggest that bupropion may be an alternative to stimulants in treating some adults with attention-deficit hyperactivity disorder.
AuthorsP H Wender, F W Reimherr
JournalThe American journal of psychiatry (Am J Psychiatry) Vol. 147 Issue 8 Pg. 1018-20 (Aug 1990) ISSN: 0002-953X [Print] United States
PMID2115746 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Antidepressive Agents
  • Monoamine Oxidase Inhibitors
  • Propiophenones
  • Bupropion
  • Methylphenidate
  • Dextroamphetamine
Topics
  • Adult
  • Antidepressive Agents (therapeutic use)
  • Attention Deficit Disorder with Hyperactivity (drug therapy)
  • Bupropion
  • Clinical Trials as Topic
  • Dextroamphetamine (therapeutic use)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Methylphenidate (therapeutic use)
  • Monoamine Oxidase Inhibitors (therapeutic use)
  • Propiophenones (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: